Receptor Tyrosine Kinases: Family and Subfamilies 2015
DOI: 10.1007/978-3-319-11888-8_17
|View full text |Cite
|
Sign up to set email alerts
|

The TrK Receptor Family

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 287 publications
0
3
0
Order By: Relevance
“…The long and truncated isoforms of the receptor were considered because of the different signalling pathways and functions. TrkB-FL, upon neurotrophin binding, leads to cell differentiation, proliferation and survival; TrkB-T1 is the dominant-negative receptor that inhibits TrkB-FL signalling, and is also known to be expressed in non-neuronal tissue such as astrocytes, bone marrow brain, heart, skeletal muscles, lungs, kidneys, and pancreas (Hondermarck et al, 2015). The TrkB-T1 pathways include regulation of extracellular BDNF concentration, activation of calcium release from intracellular stores and other intracellular signalling pathways through PKC and PLC␥ signalling cascades (Huang and Reichardt, 2001).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The long and truncated isoforms of the receptor were considered because of the different signalling pathways and functions. TrkB-FL, upon neurotrophin binding, leads to cell differentiation, proliferation and survival; TrkB-T1 is the dominant-negative receptor that inhibits TrkB-FL signalling, and is also known to be expressed in non-neuronal tissue such as astrocytes, bone marrow brain, heart, skeletal muscles, lungs, kidneys, and pancreas (Hondermarck et al, 2015). The TrkB-T1 pathways include regulation of extracellular BDNF concentration, activation of calcium release from intracellular stores and other intracellular signalling pathways through PKC and PLC␥ signalling cascades (Huang and Reichardt, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…However, as the TrkB-FL, TrkB-Shc still retains the binding site for the protein Shc and its expression varies in the same way as TrkB-FL. In addition, the TrkB-Shc receptor isoform is a membrane-bound protein, located exclusively in the brain (Stoilov et al, 2002), while the isoform TrkB-T1 is expressed ubiquitously, but predominantly in the bone marrow brain, heart, skeletal muscles, lungs, kidneys, and pancreas (Hondermarck et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Another subfamily of RTKs with multiple known heterointeractions is the tropomyosin-related kinases (Trks). This subfamily of RTKs is important for the development of the primary and periphery nervous system; the survival, maintenance, and differentiation of neurons; and the transduction of sensory signals. They primarily bind neurotrophinswhich are NGF, BDNF, neurotrophin 3 (NT-3), and neurotrophin 4/5 (NT-4/5) in mammalsbut can also be activated by a wide range of other factors . Trk overexpression and mutations are associated with a wide variety of cancers, making them an attractive therapeutic target, , as well as a wide range of neurological disorders, including Alzheimer’s, , depression, and schizophrenia …”
Section: Overview Of Known Rtk Cross-subfamily Heterointeractionsmentioning
confidence: 99%